Related references
Note: Only part of the references are listed.Evidence for and against epithelial-to-mesenchymal transition in the liver
Guanhua Xie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Epigenetic modifications as new targets for liver disease therapies
Muejdat Zeybel et al.
JOURNAL OF HEPATOLOGY (2013)
Truncated Active Human Matrix Metalloproteinase-8 Delivered by a Chimeric Adenovirus-Hepatitis B Virus Vector Ameliorates Rat Liver Cirrhosis
Jinxia Liu et al.
PLOS ONE (2013)
Effects of EZH2 Polymorphisms on Susceptibility to and Pathological Development of Hepatocellular Carcinoma
Yung-Luen Yu et al.
PLOS ONE (2013)
New therapeutic paradigm for patients with cirrhosis
Emmanuel A. Tsochatzis et al.
HEPATOLOGY (2012)
Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect
Melissa D. Yang et al.
HEPATOLOGY (2012)
Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation
Maria Jesus Perugorria et al.
HEPATOLOGY (2012)
Recombinant human hepatocyte growth factor (HGF), but not rat HGF, elicits glomerular injury and albuminuria in normal rats via an immune complex-dependent mechanism
Shinya Mizuno et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
Current status of novel antifibrotic therapies in patients with chronic liver disease
Michal Cohen-Naftaly et al.
Therapeutic Advances in Gastroenterology (2011)
MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and Fibrosis
Jelena Mann et al.
GASTROENTEROLOGY (2010)
The antifibrogenic effect of hepatocyte growth factor (HGF) on renal tubular (HK-2) cells is dependent on cell growth
Ciro Esposito et al.
GROWTH FACTORS (2009)
Targeting Liver Fibrosis: Strategies for Development and Validation of Antifibrotic Therapies
Yury Popov et al.
HEPATOLOGY (2009)
Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation
Hussein M. Atta et al.
LIVER INTERNATIONAL (2009)
Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7
Yutaka Inagaki et al.
GASTROENTEROLOGY (2008)
Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes
Masayuki Nishino et al.
SURGERY (2008)
Mammalian ASH1L is a histone methyl transferase that occupies the transcribed region of active genes
Gregory D. Gregory et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Adenoviral vector expressing hepatocyte growth factor promotes liver regeneration by preoperative injection: The advantages of performing selective injection to the remnant lobe
Masaki Ueno et al.
SURGERY (2007)
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
John P. Iredale
JOURNAL OF CLINICAL INVESTIGATION (2007)
The control of histone lysine methylation in epigenetic regulation
Pamela Volkel et al.
BIOCHIMIE (2007)
Combination gene therapy of HGF and truncated type II TGF-β receptor for rat liver cirrhosis after partial hepatectomy
S Ozawa et al.
SURGERY (2006)
Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice
Martin Roderfeld et al.
FASEB JOURNAL (2006)
Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis
WH Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3
R Cao et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Peroxisome proliferator-activated receptor γ induces a phenotypic switch from activated to quiescent hepatic stellate cells
S Hazra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats
CJ Parsons et al.
HEPATOLOGY (2004)
Inhibition on the production of collagen type I, III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid
WB Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the Transgenic mouse
H Yoshiji et al.
HEPATOLOGY (2002)
Active genes are tri-methylated at K4 of histone H3
H Santos-Rosa et al.
NATURE (2002)
Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition - Implications for reversibility of liver fibrosis
FR Murphy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells
T Rampino et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Adenovirus-mediated hepatocyte growth factor gene transfer prevents lethal liver failure in rats
T Nomi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways
YH Liu et al.
KIDNEY INTERNATIONAL (2000)
Ovarian cancer gene therapy: Repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model
A Al-Hendy et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
Share Paper
